You started Ozempic or Zepbound to drop weight, not to lose fitness. Six months in, your easy runs feel like tempo days and your legs go hollow halfway through a ride. That’s not in your head. Trial data on these drugs shows 25 to 40 percent of the weight people lose is muscle, not fat, and training load makes that loss easier to feel and harder to hide.
This isn’t a case against GLP-1 drugs. Semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) are prescription medications, and using one is a decision between you and your prescriber. This piece is about what happens after that decision, once you’re also trying to finish a marathon or an Ironman. Most of the hard numbers below come from obese, largely non-athletic trial populations in their 40s and 60s, not from trained runners and cyclists. This piece flags that gap every time it matters.
GLP-1 Drugs and Endurance Training: What the Trials Actually Show
Four major trials measured body composition, not just the number on the scale. Here’s what they found.
| Trial | Drug | Population | Weight Change | Lean Mass Share of Loss | Duration |
|---|---|---|---|---|---|
| STEP 1 (DEXA substudy) | Semaglutide | Adults with obesity | -15.0% body weight | ~40% | 68 weeks |
| SURMOUNT-1 (DXA substudy) | Tirzepatide | Adults with obesity, mean age 46 | Fat -33.9%, lean -10.9% | ~25% | 72 weeks |
| SURPASS-3 (MRI substudy) | Tirzepatide | Adults with type 2 diabetes | Muscle volume down, fat infiltration also down | Described as “comparable to general population” | 52 weeks |
| SEMALEAN | Semaglutide | Adults with obesity | Lean mass -3.0 kg by month 7, then stable | Lean % of total mass rose | 12 months |
Think of your body like a car. Fat is the gas tank. Muscle is the engine block. These drugs are built to drain the tank. Skip protein and skip strength work, and they start pulling parts from the engine instead.
Human translation: lose 20 pounds on semaglutide and do nothing else, and roughly 6 to 8 of those pounds could be muscle. On tirzepatide, the SURMOUNT-1 numbers point closer to 3 to 5 pounds out of every 20.
There’s a bright spot. The SEMALEAN trial found lean mass loss mostly happened in the first seven months, then flattened out. Grip strength actually rose, even as fat kept dropping, likely because people got lighter and moved more, not because the drug builds muscle.
Muscle loss front-loads. Protect it early, or you’re playing catch-up later.
The 45 kcal/kg Number Every GLP-1 Endurance Athlete Should Know
Appetite suppression is the whole point of these drugs. For someone already training 6 to 12 hours a week, that’s a problem waiting to happen.
Sports scientists call the shortfall low energy availability. It’s what’s left over for your body to run on after training takes its cut. The IOC’s RED-S framework (Relative Energy Deficiency in Sport) sets clear lines, measured in calories per kilogram of fat-free mass (FFM) per day.
Athletes on no drug at all already run close to this edge. One study of 45 cyclists and 55 runners found cyclists averaging just 26.9 kcal/kg of fat-free mass a day, already inside the at-risk zone, while runners averaged 34.6, sitting in the moderate-risk band.
Translation: plenty of endurance athletes are already low on fuel before anyone adds an appetite suppressant. Stack semaglutide or tirzepatide on top of a training week that already runs lean, and the math turns ugly fast.
Low energy availability isn’t just about weight. Below these thresholds, research links it to lost bone density, irregular cycles, poor sleep, more injuries, and stalled fitness gains. None of that shows up on a bathroom scale.
The scale can lie about how you’re actually doing.
How Much Protein You Actually Need on Semaglutide or Tirzepatide
Protein is the lever you control. The research gives a real number here, not just “eat more.”
The Obesity Society recommends 1.2 to 1.6 grams of protein per kilogram of body weight a day during active weight loss. The International Society of Sports Nutrition sets the bar higher for anyone doing regular resistance training: 1.4 to 2.0 g/kg a day.
| Protein Zone | Daily Intake | What It Means |
|---|---|---|
| Danger zone | Below 1.0 g/kg | Muscle loss risk climbs sharply |
| Minimum protective | 1.2-1.6 g/kg | Obesity Society target during any active weight loss |
| Athlete target | 1.4-2.0 g/kg | ISSN standard for regular resistance training |
Human translation: a 70 kg (154 lb) runner needs roughly 84 to 112 grams of protein a day at the low end of that range, more if they’re lifting.
Take a triathlete I’ll call Renee, 47, training for her third 70.3 while on tirzepatide. In month one, she was eating about 70 grams of protein a day, mostly by accident, against a 62 kg body weight. That’s 1.1 g/kg, right at the edge of the danger zone. She added a protein shake after every ride and a second one at dinner, pushing her to roughly 100 grams a day, near 1.6 g/kg. She kept two strength sessions a week. Eight months later, her DEXA scan showed lean mass down only 1.8 kg, well under what the SURMOUNT-1 average would predict for her weight loss.
No published trial has tested GLP-1 users doing structured strength training specifically, though one is finally underway. The LEAN-PREP trial, recruiting 232 participants, is the first study built to test whether resistance training, higher protein, or both protect muscle during semaglutide or tirzepatide therapy. Results aren’t out yet. Until they are, the safest bet is the one that’s always worked: lift twice a week and hit your protein number.
Why Delayed Gastric Emptying Breaks Standard Race Fueling
GLP-1 drugs work partly by slowing digestion. Food sits in your stomach longer, which is exactly why appetite drops. It’s also exactly why a gel that used to sit fine no longer does.
Nausea, bloating, and reflux show up often when solid food or a concentrated carb hits the stomach close to exercise. These GI effects tend to ease after roughly 20 weeks on the drug, as gastric motility partially adapts, but race week isn’t the time to test that for the first time.
Three shifts cover most of it. Move your pre-training meal to 3-4 hours before exercise instead of 1-2. Favor liquid calories over solid food around workouts, since liquids clear the stomach faster. Push any pre-workout supplement or caffeine dose to 30-45 minutes out instead of 15-20, since absorption slows too.
Standard fueling advice assumes a stomach that empties on a predictable clock. On a GLP-1 drug, that clock shifts, so your fueling plan has to shift with it. And when intake drops far enough, you slide into the same trap covered in why under-fueling makes endurance athletes slow, just with a medication hiding the hunger cue that would normally warn you.
This is where a fueling planner earns its keep. AthleteOS’s fueling planner checks what you log against the energy and protein demand of that day’s actual training, not a flat calorie target, so a GLP-1-suppressed appetite that’s quietly running you 400 calories and 20 grams of protein short shows up as a flagged gap instead of a mystery bad week.
Does Losing Weight on a GLP-1 Actually Make You Faster?
Not automatically. This is the part most GLP-1 articles skip.
A University of Virginia review of fitness data found something that should give every endurance athlete pause: people who lost substantial weight and fat mass on GLP-1 drugs didn’t show a matching rise in VO2max, the standard marker of aerobic fitness. They got lighter. They didn’t get objectively fitter.
No published trial has directly tested these drugs against running economy or time-trial performance in trained athletes. That gap matters. Being 15 pounds lighter helps on a climb, but only if the engine underneath, your aerobic base, is still intact. Building that base is still the job of consistent Zone 2 training, not the number on the scale.
Lighter and faster aren’t the same word.
WADA’s 2026 Monitoring Program: What “Monitored” Actually Means
If you race under WADA rules, here’s the exact status as of the 2026 list. Semaglutide and tirzepatide are Monitored substances, not Prohibited ones.
Monitoring means WADA tracks usage patterns across elite sport. It doesn’t require a therapeutic use exemption, and a positive marker is not an anti-doping violation. Neither drug appears on the 2026 Prohibited List.
Plenty of coverage blurs this into a vague “not banned” line. It’s more specific than that. WADA is watching how common these drugs become in competitive endurance sport. It isn’t sanctioning individual athletes using one under a prescription.
A Practical Framework for GLP-1 Users in Endurance Training
None of this means avoid a GLP-1 drug if you and your prescriber have decided one is right for you. It means train like the muscle loss and the fueling shift are real, because the data says they are.
Hit 1.2 to 1.6 g/kg of protein a day, minimum. Don’t let energy availability drift under 30 kcal/kg of fat-free mass. Shift your pre-workout meal window out by two hours if your stomach has changed. Lift twice a week if you can. And if a training block that used to feel manageable suddenly feels like coming back from a long illness, that’s worth a call to your prescriber, not just your coach.
Track your intake against your actual training load instead of a generic calorie target, and the gap between “lighter” and “still strong” gets a lot easier to close. Start a free AthleteOS plan and let the fueling planner run that math for you, every day, automatically.